Orthocell Ltd News

Orthocell Ltd: Outstanding 98.6% Success Rate in Striate Implant Study

May 13 19:05 ET

Orthocell Ltd: Compelling 85% Success Rate Remplir Study now published

Apr 29 19:49 ET

Orthocell Ltd: Change of Director's Interest Notice-John Van Der Wielen

Apr 23 21:52 ET

Orthocell Ltd: Securities Trading Policy

Apr 23 21:23 ET

Orthocell Ltd: Change of Director's Interest Notice-John Van Der Wielen

Apr 15 18:56 ET

Orthocell Ltd: Orthocell receives $3.05m R&D tax incentive refund

Apr 14 19:03 ET

Orthocell Ltd: Quarterly Activity Report & Appendix 4C

Apr 7 19:03 ET

Orthocell Ltd: Part 1 Remplir US Market Authorisation Successfully Complete

Mar 24 18:19 ET

Orthocell Ltd: Cleansing Notice

Mar 11 03:06 ET

Orthocell Ltd: Application for quotation of securities - OCC

Mar 11 03:05 ET

Orthocell Ltd: Application for quotation of securities - OCC

Mar 11 03:04 ET

Orthocell Ltd: Cleansing Notice

Feb 27 18:27 ET

Orthocell Ltd: Application for quotation of securities - OCC

Feb 27 18:24 ET

Orthocell Ltd: Appendix 4D & Half-Year Financial Statements

Feb 22 23:27 ET

Orthocell Ltd: Proposed issue of securities - OCC

Feb 21 17:20 ET

Orthocell Ltd: Strategic Placement to Raise $3.5 million

Feb 21 17:20 ET

Orthocell Ltd: Trading Halt

Feb 19 17:43 ET

Orthocell Ltd: Remplir Expansion Continues with Singapore Application

Feb 12 17:14 ET

Orthocell Ltd: Notification of cessation of securities - OCC

Feb 5 16:15 ET

Orthocell Ltd: Quarterly Activity Report & Appendix 4C

Jan 28 16:57 ET